Open AccessVentilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina
Author(s) -
Norma Fernández,
Diego H. Cáceres,
Karlyn D. Beer,
Célica Irrazábal,
Ghilka Delgado,
Luciana Farías,
Tom Chiller,
Paul E. Verweij,
Daniel Stecher
Publication year - 2020
Publication title -
medical mycology case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.422
H-Index - 15
ISSN - 2211-7539
DOI - 10.1016/j.mmcr.2020.07.001
Subject(s) - medicine , pneumonia , aspergillosis , covid-19 , coronavirus , complication , aspergillus flavus , intensive care medicine , disease , pandemic , virology , immunology , infectious disease (medical specialty) , microbiology and biotechnology , biology
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has been reported as a complication of severe influenza pneumonia among intensive care patients. Similarities between COVID-19 and influenza pneumonia, together with limited published case series, suggest that aspergillosis may be an important complication of COVID-19. This report describes a case of ventilator-associated pneumonia involving Aspergillus flavus in a patient with COVID-19 from Buenos Aires, Argentina.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom